Novonesis (Novozymes) B (CHIX:NSISBC) Days Sales Outstanding : 0.00 (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Novonesis (Novozymes) B Days Sales Outstanding?

Novonesis (Novozymes) B's average Accounts Receivable for the three months ended in Jun. 2024 was kr4,396 Mil. Novonesis (Novozymes) B's Revenue for the three months ended in Jun. 2024 was kr0 Mil.

The historical rank and industry rank for Novonesis (Novozymes) B's Days Sales Outstanding or its related term are showing as below:

CHIX:NSISBc' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.56 Med: 66.85 Max: 81.84
Current: 81.84

During the past 13 years, Novonesis (Novozymes) B's highest Days Sales Outstanding was 81.84. The lowest was 62.56. And the median was 66.85.

CHIX:NSISBc's Days Sales Outstanding is ranked worse than
68.13% of 1528 companies
in the Chemicals industry
Industry Median: 65.215 vs CHIX:NSISBc: 81.84

Novonesis (Novozymes) B's Days Sales Outstanding declined from Mar. 2023 (69.90) to Jun. 2024 (0.00).

Novonesis (Novozymes) B Days Sales Outstanding Historical Data

The historical data trend for Novonesis (Novozymes) B's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Days Sales Outstanding Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

69.43

70.50

67.10

66.60

72.87

Novonesis (Novozymes) B Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															69.90	78.70	74.89	72.08	-

Competitive Comparison of Novonesis (Novozymes) B's Days Sales Outstanding

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's Days Sales Outstanding Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Days Sales Outstanding falls into.

Novonesis (Novozymes) B Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Novonesis (Novozymes) B's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3448.713	+	3706.109)	/	2 )	/	17918.848	*	365
=	3577.411					/	17918.848	*	365
=	72.87

Novonesis (Novozymes) B's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (3706.109	+	5086.381)	/	2 )	/	0	*	365 / 4
=	4396.245					/	0	*	365 / 4
=	N/A

Novonesis (Novozymes) B (CHIX:NSISBc) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Novonesis (Novozymes) B Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (CHIX:NSISBc) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA 0Q4U:UK NSIS B:Denmark NZM2:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines